Differential expression of remodeling markers by tissue structure in nasal polyposis

American Journal of Rhinology and Allergy

Volumn 27, Issue 3, 2013, Pages

  De Borja Callejas, Francisco ^a,b   Picado, Cesar ^b,c   Martínez Antón, Asunción ^b   Alobid, Isam ^d   Pujols, Laura ^a   Valero, Antonio ^c   Roca Ferrer, Jordi ^b   Mullol, Joaquim ^b,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c Departments of Pneumology and Allergy   (Spain)

^d Rhinology Unit and Smell Clinic   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; CELL INFILTRATION; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPIC SINUS SURGERY; EOSINOPHIL; EPITHELIUM; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NOSE MUCOSA; NOSE POLYP; PROTEIN EXPRESSION; TISSUE STRUCTURE;

BIOLOGICAL MARKERS; CHRONIC DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES; NASAL MUCOSA; NASAL POLYPS; RHINITIS; SINUSITIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 84878294978     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.3908     Document Type: Article

References (34)

1. Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 50: 1-12, 2012.
2. Eloy P, Poirrier AL, De Dorlodot C, et al. Actual concepts in rhinosinusitis: A review of clinical presentations, inflammatory pathways, cytokine profiles, remodeling, and management. Curr Allergy Asthma Rep 11: 146-162, 2011.
3. Payne SC, Borish L, and Steinke JW. Genetics and phenotyping in chronic sinusitis. J Allergy Clin Immunol 128: 710-720, 2011.
4. Tomassen P, Van Zele T, Zhang N, et al. Pathophysiology of chronic rhinosinusitis. Proc Am Thorac Soc 8: 115-120, 2011.
5. Hsu J, and Peters AT. Pathophysiology of chronic rhinosinusitis with nasal polyp. Am J Rhinol Allergy 25: 285-290, 2011.
6. Watelet JB, Van Zele T, Gjomarkaj M, et al. Tissue remodelling in upper airways: Where is the link with lower airway remodelling? Allergy 61: 1249-1258, 2006.
7. Bassiouni A, Naidoo Y, and Wormald PJ. Does mucosal remodeling in chronic rhinosinusitis result in irreversible mucosal disease? Laryngoscope 122: 225-229, 2012.
8. Van Crombruggen K, Zhang N, Gevaert P, et al. Pathogenesis of chronic rhinosinusitis: Inflammation. J Allergy Clin Immunol 128: 728-732, 2011.
9. Cao PP, Li HB, Wang BF, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol 124: 478-484, 2009.
10. Zhang N, Holtappels G, Claeys C, et al. Pattern of inflammation and impact of Staphylococcus aureus enterotoxins in nasal polyps from southern China. Am J Rhinol 20: 445-450, 2006.
11. Zhang N, Van Zele T, Perez-Novo C, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 122: 961-968, 2008.
12. Mainz JG, and Koitschev A. Pathogenesis and management of nasal polyposis in cystic fibrosis. Curr Allergy Asthma Rep 12: 163-174, 2012.
13. Li X, Meng J, Qiao X, et al. Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis. J Allergy Clin Immunol 125: 1061-1068, 2010.
14. Al-Muhsen S, Johnson JR, and Hamid Q. Remodeling in asthma. J Allergy Clin Immunol 128: 451-462, 2011.
15. Müller-Quernheim J. MMPs are regulatory enzymes in pathways of inflammatory disorders, tissue injury, malignancies and remodelling of the lung. Eur Respir J 38: 12-14, 2011.
16. Wang JH, Kwon HJ, and Jang YJ. Staphylococcus aureus increases cytokine and matrix metalloproteinase expression in nasal mucosae of patients with chronic rhinosinusitis and nasal polyps. Am J Rhinol Allergy 24: 422-427, 2010.
17. Kostamo K, Toskala E, Tervahartiala T, and Sorsa T. Role of matrix metalloproteinases in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol 8: 21-27, 2008.
18. Van Bruaene N, and Bachert C. Tissue remodeling in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol 11: 8-11, 2011.
19. Can IH, Ceylan K, Caydere M, et al. The expression of MMP-2, MMP-7, MMP-9, and TIMP-1 in chronic rhinosinusitis and nasal polyposis. Otolaryngol Head Neck Surg 139: 211-215, 2008.
20. Eyibilen A, Cayli S, Aladag I, et al. Distribution of matrix metalloproteinases MMP-1, MMP-2, MMP-8, and tissue inhibitor of matrix metalloproteinases-2 in nasal polyposis and chronic rhinosinusitis. Histol Histopathol 26: 615-621, 2011.
21. Watelet JB, Bachert C, Claeys C, and Van Cauwenberge P. Matrix metalloproteinases MMP-7, MMP-9, and their tissue inhibitor TIMP-1: Expression in chronic sinusitis vs nasal polyposis. Allergy 59: 54-60, 2004.
22. Bugdayci G, Kaymakci M, and Bukan N. Matrix metalloproteinase-9 (MMP-9) in allergic nasal polyps. Acta histochemica 112: 92-95, 2010.
23. Chen YS, Langhammer T, Westhofen M, and Lorenzen J. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps. Allergy 62: 66-72, 2007.
24. Kostamo K, Tervahartiala T, Sorsa T, et al. Metalloproteinase function in chronic rhinosinusitis with nasal polyposis. Laryngoscope 117: 638-643, 2007.
25. Shin HW, Han DH, Lim YS, et al. Nonasthmatic nasal polyposis patients with allergy exhibit greater epithelial MMP positivity. Otolaryngol Head Neck Surg 141: 442-447, 2009.
26. Lee YM, Kim SS, Kim HA, et al. Eosinophil inflammation of nasal polyp tissue: Relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factorbeta1. J Korean Med Sci 18: 97-102, 2003.
27. Casadevall J, Ventura PJ, Mullol J, and Picado C. Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: Evaluation of nasal response by acoustic rhinometry. Thorax 55: 921-924, 2000.
28. Leonardi A, Brun P, Di Stefano A, et al. Matrix metalloproteases in vernal keratoconjunctivitis, nasal polyps and allergic asthma. Clin Exp Allergy 37: 872-879, 2007.
29. Sternlicht MD, and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2001.
30. Wang LF, Chien CY, Chiang FY, et al. Corelationship between matrix metalloproteinase 2 and 9 expression and severity of chronic rhinosinusitis with nasal polyposis. Am J Rhinol Allergy 26:e1-e4, 2012.
31. Lechapt-Zalcman E, Coste A, d'Ortho MP, et al. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 193: 233-241, 2001.
32. Eisenberg G, Pradillo J, Plaza G, et al. Increased expression and activity of MMP-9 in chronic rhinosinusitis with nasal polyposis. Acta Otorrinolaringol Esp 59: 444-447, 2008.
33. Kahveci OK, Derekoy FS, Yilmaz M, et al. The role of MMP-9 and TIMP-1 in nasal polyp formation. Swiss Med Wkly 138: 684-688, 2008.
34. Bhandari A, Takeuchi K, Suzuki S, et al. Increased expression of matrix metalloproteinase-2 in nasal polyps. Acta Otolaryngol 124: 1165-1170, 2004.